Chlamydia trachomatis is the most common cause of sexually transmitted diseases worldwide; yet, there remains a need for a rapid and economical diagnostic test. Such an assay must be economical, readily standardized among laboratories, objective, quantitative, rapid, easy to use, and capable of detecting serovariant-specific responses. Work at UC Berkeley has lead to development of peptide antigens useful for producing such an immunoassay test.
Useful for sensitive detecton of of anti-chlamydial antibodies in serum, plasma, tears, cervical secretions, and other bodily fluids.
diagnostic, detection